Evidence map›Paper›PMID 40567347›Full record

ArticleEClinicalMedicine2025

Identification and validation of an explainable early-stage chronic kidney disease prediction model: a multicenter retrospective study.

Jiayi He, Xin Wang, Peiqi Zhu, Xiaoxu Wang, Yitong Zhang, Jing Zhao, Wei Sun, Kongfa Hu, Weiming He, Jiadong Xie

Abstract read
In one paragraph

Article in EClinicalMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jiayi HeSchool of Artificial Intelligence and Information Technology, Nanjing University of Chinese Medicine, Nanjing, China.
Xin WangSuzhou Hospital of Integrated Traditional Chinese and Western Medicine, Suzhou, China.
Peiqi ZhuAffiliated Hospital of Nanjing University of Chinese Medicine/Jiangsu Province Hospital of Chinese Medicine, Nanjing, China.
Xiaoxu WangDepartment of Nephrology, Zhongda Hospital, Southeast University School of Medicine, Nanjing, China.
Yitong ZhangSchool of Artificial Intelligence and Information Technology, Nanjing University of Chinese Medicine, Nanjing, China.
Jing ZhaoAffiliated Hospital of Nanjing University of Chinese Medicine/Jiangsu Province Hospital of Chinese Medicine, Nanjing, China.
Wei SunAffiliated Hospital of Nanjing University of Chinese Medicine/Jiangsu Province Hospital of Chinese Medicine, Nanjing, China.
Kongfa HuSchool of Artificial Intelligence and Information Technology, Nanjing University of Chinese Medicine, Nanjing, China.
Weiming HeAffiliated Hospital of Nanjing University of Chinese Medicine/Jiangsu Province Hospital of Chinese Medicine, Nanjing, China.
Jiadong XieSchool of Artificial Intelligence and Information Technology, Nanjing University of Chinese Medicine, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Chronic Kidney Disease (CKD) has become a significant global public health issue, affecting approximately 10% of adults. Due to the lack of obvious symptoms in the early stages, CKD is often difficult to diagnose in a timely manner, leading to the gradual progression of the disease, which can eventually develop into End-Stage Renal Disease (ESRD). This study applied machine learning (ML) methods to integrate patient clinical data and developed an early CKD prediction model applicable to individuals Methods: This study is a retrospective multicenter study conducted in China, including patients with CKD and healthy individuals who underwent physical examinations from February 2021 to April 2024. Six ML methods, including Decision Tree, Multilayer Perceptron, and XGBoost, were used to predict CKD, integrating different combinations of features such as blood routine, urine analysis, and blood biochemistry. Multiple evaluation metrics, including AUC and F1 score, were used to compare the prediction performance. The SHAP interpretability method was applied to assess feature importance and explain the final model's results. Findings: Data from three hospitals were used in this study, with the dataset divided into training and internal validation sets (CKD: 11,436 cases, non-CKD: 10,004 cases) and an external validation set (CKD: 350 cases, non-CKD: 473 cases). Among the six ML models, XGBoost performed the best. Regarding feature combinations, the "blood routine + urinalysis + basic information" combination yielded the best performance (AUC = 0.9235, external validation AUC = 0.8962). Additionally, a web tool was developed in this study to facilitate the application of early CKD risk prediction in clinical practice. Interpretation: This study applied an interpretable ML model to effectively predict early CKD. Even when using the relatively low-cost "blood routine + urinalysis + basic information" combination, the model still demonstrated high prediction accuracy. This method has potential clinical application prospects and may help identify early CKD, reducing the risk of disease progression. Funding: This research was supported by the National Key Research and Development Program of China (2023YFC3502903, 2022YFC3502302), National Natural Science Foundation of China (82074580), and Science and Technology Project of Jiangsu Provincial Research Institute of Chinese Medicine Schools (JSZYLP2024011).

Indexed as

Chronic kidney diseaseEarly predictionMachine learningPrediction modelSHAP

Identifiers

PMID40567347
PMCPMC12192353

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.